Kynacyte: Began a Phase I trial

Sphinx Pharmaceuticals Corp. (SPHX) Product: Kynacyte (safingol), protein kinase C inhibitor, used alone and in combination with doxorubicin Indication: Cancer Status: Began a Phase I trial ...